References:
  1. Velavan TP, Meyer CG: The COVID-19 epidemic. Trop Med Int Health 2020:25(3): 278-280.
  2. Kannan S, Shaik S, Ali P, et al: COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020:24(4):2006-2011.
  3. Zheng YY, Ma YT, Zhang JY, et al: COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020:17(5):259-260.
  4. Li B, Yang J, Zhao F, Zhi L, et al: Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020:109(5):531-538.
  5. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev 2020:14(3):247-250.
  6. Hendren NS, Drazner MH, Bozkurt B, et al: Description and proposed management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. Published online April 16, 2020.
  7. Riphagen S, Gomez X, Gonzalez-Martinez C, et al: Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. Published online May 6, 2020.
  8. Mehta P, McAuley DF, Brown M, et al: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020:395(10229):1033-1034.
  9. Tunuguntla H, Jeewa A, Denfield S. Acute myocarditis and pericarditis in children. Pediatr Rev: 2019:40(1):14-25.
  10. Friedrich M, Sechtem U, Schulz-Menger J, et al: International consensus group on cardiovascular magnetic resonance in myocarditis. cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009:53(17):1475-87.